Organ Transplant Rejection: Immune Mechanisms and Prevention Strategies

Transplant rejection occurs when the recipient’s immune system recognizes the donor organ as foreign.

Key Mechanisms

  1. Acute rejection (days–months): Host T cells recognize donor MHC (HLA) mismatches → direct/indirect allorecognition → cytotoxic attack, cytokine storm.
  2. Hyperacute rejection (minutes–hours): Pre-existing anti-donor antibodies (ABO or HLA) → complement activation → immediate graft thrombosis.
  3. Chronic rejection (months–years): Antibody-mediated vascular remodeling (transplant vasculopathy), fibrosis, gradual function loss.
  4. Antibody-mediated rejection (AMR): Donor-specific antibodies (DSA) → endothelial injury, C4d deposition.
  5. Ischemia-reperfusion injury: Procurement/storage damage → inflammation → upregulates immunogenicity.

Prevention & Management

  • HLA matching (best for kidney).
  • Induction immunosuppression (thymoglobulin, basiliximab).
  • Maintenance: calcineurin inhibitor + antimetabolite + steroid (tailored).
  • Monitoring: protocol biopsies, DSA surveillance, gene expression profiling.
  • Treatment of rejection: pulse steroids, T-cell depletion, plasmapheresis/IVIG for AMR.

Despite advances, rejection remains the major barrier to long-term graft survival.

Kidney Disease - Related Articles